COVID-19 in a kidney transplant recipient treated with eculizumab for atypical hemolytic uremic syndrome: a case report.

Cognard, Noëlle; Gautier-Vargas, Gabriela; Perrin, Peggy; Benotmane, Ilies; Caillard, Sophie

Cognard, Noëlle; Gautier-Vargas, Gabriela; Perrin, Peggy; Benotmane, Ilies; Caillard, Sophie.

Cognard N; Department of Nephrology and Transplantation, Strasbourg University Hospital, Strasbourg, France. noelle.cognard@chru-strasbourg.fr.
Gautier-Vargas G; Department of Nephrology and Transplantation, Strasbourg University Hospital, Strasbourg, France.
Perrin P; Department of Nephrology and Transplantation, Strasbourg University Hospital, Strasbourg, France.
Benotmane I; Department of Nephrology and Transplantation, Strasbourg University Hospital, Strasbourg, France.
Caillard S; Department of Nephrology and Transplantation, Strasbourg University Hospital, Strasbourg, France.

J Nephrol ; 34(4): 1045-1048, 2021 08.

Article in English | MEDLINE | ID: covidwho-1230312

Subject(s)

Atypical Hemolytic Uremic Syndrome; COVID-19; Kidney Transplantation; Antibodies, Monoclonal, Humanized; Atypical Hemolytic Uremic Syndrome/diagnosis; Atypical Hemolytic Uremic Syndrome/drug therapy; Humans; Kidney Transplantation/adverse effects; SARS-CoV-2

Keywords

COVID-19; Case report; Eculizumab; Kidney transplantation

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Kidney Transplantation / Atypical Hemolytic Uremic Syndrome / COVID-19 Type of study: Case report / Diagnostic study Limits: Humans Language: English Journal: J Nephrol Journal subject: Nephrology Year: 2021 Document Type: Article Affiliation country: S40620-021-01057-3

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google